{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:47:51Z","timestamp":1790203671856,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Medical Science and Technology in Henan Province","award":["Grant No. SBGJ202101016"],"award-info":[{"award-number":["Grant No. SBGJ202101016"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82171300"],"award-info":[{"award-number":["Grant No. 82171300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84362-8","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:48:51Z","timestamp":1736336931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson\u2019s disease and insomnia"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Han","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"9996","key":"84362_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet (London, England) 386(9996), 896\u2013912 (2015).","journal-title":"Lancet (London, England)"},{"issue":"7","key":"84362_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18(7), 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"84362_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79(4), 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"84362_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2006.100370","volume":"78","author":"MD Gjerstad","year":"2007","unstructured":"Gjerstad, M. D. et al. Insomnia in Parkinson\u2019s disease: Frequency and progression over time. J. Neurol. Neurosurg. Psychiatry 78(5), 476\u2013479 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"84362_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/mds.20874","volume":"21","author":"JC G\u00f3mez-Esteban","year":"2006","unstructured":"G\u00f3mez-Esteban, J. C. et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson\u2019s disease. Mov. Disorders: Off. J. Mov. Disorder Soc. 21(7), 983\u2013988 (2006).","journal-title":"Mov. Disorders: Off. J. Mov. Disorder Soc."},{"issue":"1","key":"84362_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00415-020-10140-x","volume":"268","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Progression of sleep disturbances in Parkinson\u2019s disease: A 5-year longitudinal study. J. Neurol. 268(1), 312\u2013320 (2021).","journal-title":"J. Neurol."},{"issue":"3","key":"84362_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JPD-191627","volume":"9","author":"NI Bohnen","year":"2019","unstructured":"Bohnen, N. I. & Hu, M. T. M. Sleep disturbance as potential risk and progression factor for Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 9(3), 603\u2013614 (2019).","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"11","key":"84362_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis, M. et al. Parkinson\u2019s disease symptoms: The patient\u2019s perspective. Mov. Disorders: Off. J. Mov. Disorder Soc. 25(11), 1646\u20131651 (2010).","journal-title":"Mov. Disorders: Off. J. Mov. Disorder Soc."},{"issue":"10","key":"84362_CR9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamaneurol.2020.1623","volume":"77","author":"Y Leng","year":"2020","unstructured":"Leng, Y. et al. Association of circadian abnormalities in older adults with an increased risk of developing Parkinson disease. JAMA Neurol. 77(10), 1270\u20131278 (2020).","journal-title":"JAMA Neurol."},{"issue":"8","key":"84362_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/brainsci13081202","volume":"13","author":"S Thangaleela","year":"2023","unstructured":"Thangaleela, S. et al. Neurological insights into sleep disorders in Parkinson\u2019s disease. Brain Sci. 13(8), 1202 (2023).","journal-title":"Brain Sci."},{"issue":"4","key":"84362_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1212\/WNL.0000000000003540","volume":"88","author":"LK Tholfsen","year":"2017","unstructured":"Tholfsen, L. K. et al. Changes in insomnia subtypes in early Parkinson disease. Neurology 88(4), 352\u2013358 (2017).","journal-title":"Neurology"},{"issue":"7","key":"84362_CR12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3233\/JPD-212749","volume":"12","author":"L Sch\u00fctz","year":"2022","unstructured":"Sch\u00fctz, L., Sixel-D\u00f6ring, F. & Hermann, W. Management of sleep disturbances in Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 12(7), 2029\u20132058 (2022).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"84362_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.parkreldis.2016.09.010","volume":"33","author":"K Zhu","year":"2016","unstructured":"Zhu, K., van Hilten, J. J. & Marinus, J. The course of insomnia in Parkinson\u2019s disease. Parkinsonism Relat. Disorders 33, 51\u201357 (2016).","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"3","key":"84362_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.14336\/AD.2022.0916","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Tryptophan metabolism in central nervous system diseases: Pathophysiology and potential therapeutic strategies. Aging Dis. 14(3), 858\u2013878 (2023).","journal-title":"Aging Dis."},{"key":"84362_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12974-015-0328-2","volume":"12","author":"EB Yan","year":"2015","unstructured":"Yan, E. B. et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J. Neuroinflamm. 12, 110 (2015).","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"84362_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jocn.2013.08.020","volume":"21","author":"X Mo","year":"2014","unstructured":"Mo, X. et al. Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke. J. Clin. Neurosci.: Off. J. Neurosurg.Soc. Australas. 21(3), 482\u2013486 (2014).","journal-title":"J. Clin. Neurosci.: Off. J. Neurosurg.Soc. Australas."},{"key":"84362_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bbi.2020.03.002","volume":"87","author":"TB Meier","year":"2020","unstructured":"Meier, T. B. et al. Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites. Brain Behav. Immun. 87, 715\u2013724 (2020).","journal-title":"Brain Behav. Immun."},{"key":"84362_CR18","doi-asserted-by":"publisher","first-page":"117864692097090","DOI":"10.1177\/1178646920970902","volume":"13","author":"A Bhat","year":"2020","unstructured":"Bhat, A. et al. Effects of sleep deprivation on the tryptophan metabolism. Int. J. Tryptophan Res.: IJTR 13, 1178646920970902 (2020).","journal-title":"Int. J. Tryptophan Res.: IJTR"},{"issue":"8","key":"84362_CR19","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1007\/s12035-017-0845-3","volume":"55","author":"K-H Chang","year":"2018","unstructured":"Chang, K.-H. et al. Alternations of metabolic profile and kynurenine metabolism in the plasma of Parkinson\u2019s disease. Mol. Neurobiol. 55(8), 6319\u20136328 (2018).","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"84362_CR20","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/mds.28202","volume":"35","author":"PL Heilman","year":"2020","unstructured":"Heilman, P. L. et al. Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s disease. Mov. Disorders\u202f: Off. J. Mov. Disorder Soc. 35(11), 2028\u20132037 (2020).","journal-title":"Mov. Disorders : Off. J. Mov. Disorder Soc."},{"key":"84362_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100270","volume":"21","author":"D Venkatesan","year":"2020","unstructured":"Venkatesan, D. et al. Kynurenine pathway in Parkinson\u2019s disease\u2014an update. ENeurologicalSci 21, 100270 (2020).","journal-title":"ENeurologicalSci"},{"issue":"2","key":"84362_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10284150500069561","volume":"8","author":"C Hudson","year":"2005","unstructured":"Hudson, C. et al. Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia. Nutr. Neurosci. 8(2), 121\u2013127 (2005).","journal-title":"Nutr. Neurosci."},{"issue":"6","key":"84362_CR23","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/nu12061885","volume":"12","author":"O Saidi","year":"2020","unstructured":"Saidi, O. et al. Randomized double-blind controlled trial on the effect of proteins with different tryptophan\/large neutral amino acid ratios on sleep in adolescents: The PROTMORPHEUS study. Nutrients 12(6), 1885 (2020).","journal-title":"Nutrients"},{"key":"84362_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2021.01.013","volume":"80","author":"S Mithani","year":"2021","unstructured":"Mithani, S. et al. Whole blood transcriptome analysis using RNA sequencing in individuals with insomnia disorder and good sleepers: A pilot study. Sleep Med. 80, 1\u20138 (2021).","journal-title":"Sleep Med."},{"issue":"1","key":"84362_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s42003-024-06684-7","volume":"7","author":"A Guvenek","year":"2024","unstructured":"Guvenek, A. et al. Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration. Commun. Biol. 7(1), 1168 (2024).","journal-title":"Commun. Biol."},{"issue":"5","key":"84362_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jnc.14809","volume":"150","author":"M Fayyad","year":"2019","unstructured":"Fayyad, M. et al. Parkinson\u2019s disease biomarkers based on \u03b1-synuclein. J. Neurochem. 150(5), 626\u2013636 (2019).","journal-title":"J. Neurochem."},{"issue":"1","key":"84362_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41531-024-00790-3","volume":"10","author":"L-L Xiong","year":"2024","unstructured":"Xiong, L.-L. et al. Single-cell RNA sequencing reveals peripheral immunological features in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 10(1), 185 (2024).","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"3","key":"84362_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.b.30272","volume":"141B","author":"PF Sullivan","year":"2006","unstructured":"Sullivan, P. F., Fan, C. & Perou, C. M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. Part B, Neuropsychiatric Genet. Off. Publ. Int. Soc. sychiatric Genet. 141B(3), 261\u2013268 (2006).","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric Genet. Off. Publ. Int. Soc. sychiatric Genet."},{"issue":"1","key":"84362_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30(1), 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"84362_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1(6), 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"84362_CR31","first-page":"bax028","volume":"2017","author":"S Fishilevich","year":"2017","unstructured":"Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database J. Biol. Databases Curation 2017, bax028 (2017).","journal-title":"Database J. Biol. Databases Curation"},{"issue":"7","key":"84362_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"84362_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.56","volume":"2","author":"K Ito","year":"2013","unstructured":"Ito, K. & Murphy, D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacomet. Syst. Pharmacol. 2(10), e79 (2013).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"issue":"5","key":"84362_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J. Integr. Biol. 16(5), 284\u2013287 (2012).","journal-title":"Omics: J. Integr. Biol."},{"issue":"D1","key":"84362_CR35","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49(D1), D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"84362_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"Suppl 4","key":"84362_CR37","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin, C.-H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8(Suppl 4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"84362_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader, G. D. & Hogue, C. W. V. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 4, 2 (2003).","journal-title":"BMC Bioinform."},{"key":"84362_CR39","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2147\/COPD.S271237","volume":"15","author":"J Xia","year":"2020","unstructured":"Xia, J. et al. A model using support vector machines recursive feature elimination (SVM-RFE) algorithm to classify whether COPD patients have been continuously managed according to GOLD guidelines. Int. J. Chronic Obstr. Pulm. Dis. 15, 2779\u20132786 (2020).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"84362_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fdata.2020.00015","volume":"3","author":"A Sharma","year":"2020","unstructured":"Sharma, A. & Verbeke, W. J. M. I. Improving diagnosis of depression with XGBOOST machine learning model and a large biomarkers dutch dataset (n = 11,081). Front. Big Data 3, 15 (2020).","journal-title":"Front. Big Data"},{"key":"84362_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen, B. et al. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. 1711, 243\u2013259 (2018).","journal-title":"Methods Mol. Biol."},{"key":"84362_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"43","key":"84362_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102(43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"84362_CR44","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214\u2013W220 (2010).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"84362_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nmeth.2689","volume":"10","author":"M Griffith","year":"2013","unstructured":"Griffith, M. et al. DGIdb: Mining the druggable genome. Nat. Methods 10(12), 1209\u20131210 (2013).","journal-title":"Nat. Methods"},{"issue":"D1","key":"84362_CR46","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 52(D1), D174\u2013D182 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"84362_CR47","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou, G. et al. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47(W1), W234\u2013W241 (2019).","journal-title":"Nucleic Acids Res."},{"key":"84362_CR48","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"J-H Li","year":"2014","unstructured":"Li, J.-H. et al. starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92\u2013D97 (2014).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"84362_CR49","doi-asserted-by":"publisher","first-page":"W135","DOI":"10.1093\/nar\/gkw288","volume":"44","author":"Y Fan","year":"2016","unstructured":"Fan, Y. et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res. 44(W1), W135\u2013W141 (2016).","journal-title":"Nucleic Acids Res."},{"key":"84362_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejogrb.2021.04.012","volume":"261","author":"S Guerriero","year":"2021","unstructured":"Guerriero, S. et al. Artificial intelligence (AI) in the detection of rectosigmoid deep endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 261, 29\u201333 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"84362_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"84362_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14521","volume":"30","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy, H. M. et al. Sleep disorders cause Parkinson\u2019s disease or the reverse is true: Good GABA good night. CNS Neurosci. Ther. 30(3), e14521 (2024).","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"84362_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jsr.12545","volume":"26","author":"Y-H Hsiao","year":"2017","unstructured":"Hsiao, Y.-H. et al. Sleep disorders and an increased risk of Parkinson\u2019s disease in individuals with non-apnea sleep disorders: A population-based cohort study. J. Sleep Res. 26(5), 623\u2013628 (2017).","journal-title":"J. Sleep Res."},{"issue":"8","key":"84362_CR54","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/aje\/kwj096","volume":"163","author":"H Chen","year":"2006","unstructured":"Chen, H. et al. A prospective study of night shift work, sleep duration, and risk of Parkinson\u2019s disease. Am. J. Epidemiol. 163(8), 726\u2013730 (2006).","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"84362_CR55","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Tryptophan metabolism in health and disease. Cell Metab. 35(8), 1304\u20131326 (2023).","journal-title":"Cell Metab."},{"key":"84362_CR56","doi-asserted-by":"publisher","first-page":"3924608","DOI":"10.1155\/2018\/3924608","volume":"2018","author":"Z Dutkiewicz","year":"2018","unstructured":"Dutkiewicz, Z. & Mikstacka, R. Structure-based drug design for cytochrome P450 family 1 inhibitors. Bioinorg. Chem. Appl. 2018, 3924608 (2018).","journal-title":"Bioinorg. Chem. Appl."},{"key":"84362_CR57","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.sleep.2024.10.020","volume":"124","author":"R Sugumaran","year":"2024","unstructured":"Sugumaran, R. et al. Melatonin on sleep in Parkinson\u2019s disease: A randomized double blind placebo controlled trial. Sleep Med. 124, 502\u2013509 (2024).","journal-title":"Sleep Med."},{"key":"84362_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102480","volume":"101","author":"RJ Reiter","year":"2024","unstructured":"Reiter, R. J. et al. Dysfunctional mitochondria in age-related neurodegeneration: Utility of melatonin as an antioxidant treatment. Ageing Res. Rev. 101, 102480 (2024).","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"84362_CR59","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1002\/jcb.27794","volume":"120","author":"G Xu","year":"2019","unstructured":"Xu, G. et al. Melatonin ameliorates spinal cord injury by suppressing the activation of inflammasomes in rats. J. Cell. Biochem. 120(4), 5183\u20135192 (2019).","journal-title":"J. Cell. Biochem."},{"issue":"18","key":"84362_CR60","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.3390\/cells11182809","volume":"11","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Melatonin attenuates spinal cord injury in mice by activating the Nrf2\/ARE signaling pathway to inhibit the NLRP3 inflammasome. Cells 11(18), 2809 (2022).","journal-title":"Cells"},{"issue":"10","key":"84362_CR61","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.3390\/ijms25105122","volume":"25","author":"G Bocheva","year":"2024","unstructured":"Bocheva, G. et al. The vital role of melatonin and its metabolites in the neuroprotection and retardation of brain aging. Int. J. Mol. Sci. 25(10), 5122 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"84362_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/metabo13050629","volume":"13","author":"A Haduch","year":"2023","unstructured":"Haduch, A. et al. The engagement of cytochrome P450 enzymes in tryptophan metabolism. Metabolites 13(5), 629 (2023).","journal-title":"Metabolites"},{"key":"84362_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"M-F Sun","year":"2018","unstructured":"Sun, M.-F. & Shen, Y.-Q. Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res. Rev. 45, 53\u201361 (2018).","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"84362_CR64","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6), 1469 (2016).","journal-title":"Cell"},{"key":"84362_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101691","volume":"65","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. The microbiota-gut-brain axis in sleep disorders. Sleep Med. Rev. 65, 101691 (2022).","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"84362_CR66","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/ijms25052915","volume":"25","author":"P Iwaniak","year":"2024","unstructured":"Iwaniak, P., Owe-Larsson, M. & Urba\u0144ska, E. M. Microbiota, tryptophan and aryl hydrocarbon receptors as the target triad in Parkinson\u2019s disease-a narrative review. Int. J. Mol. Sci. 25(5), 2915 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"84362_CR67","doi-asserted-by":"publisher","first-page":"1433747","DOI":"10.3389\/fncel.2024.1433747","volume":"18","author":"L Coretti","year":"2024","unstructured":"Coretti, L., Buommino, E. & Lembo, F. The aryl hydrocarbon receptor pathway: A linking bridge between the gut microbiome and neurodegenerative diseases. Front. Cell. Neurosci. 18, 1433747 (2024).","journal-title":"Front. Cell. Neurosci."},{"key":"84362_CR68","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/intimm\/dxae035","volume":"36","author":"K Miyamoto","year":"2024","unstructured":"Miyamoto, K., Sujino, T. & Kanai, T. The tryptophan metabolic pathway of the microbiome and host cells in health and disease. Int. Immunol. 36, 601\u2013616 (2024).","journal-title":"Int. Immunol."},{"issue":"3","key":"84362_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14633","volume":"30","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. CYP1B1 affects the integrity of the blood-brain barrier and oxidative stress in the striatum: An investigation of manganese-induced neurotoxicity. CNS Neurosci. Ther. 30(3), e14633 (2024).","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"84362_CR70","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41419-022-05223-8","volume":"13","author":"T Lei","year":"2022","unstructured":"Lei, T. et al. ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt\/\u03b2-catenin pathway. Cell Death Dis 13(9), 781 (2022).","journal-title":"Cell Death Dis"},{"issue":"7","key":"84362_CR71","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.4103\/1673-5374.386398","volume":"19","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Activation of the Wnt\/\u03b2-catenin\/CYP1B1 pathway alleviates oxidative stress and protects the blood-brain barrier under cerebral ischemia\/reperfusion conditions. Neural Regen. Res. 19(7), 1541\u20131547 (2024).","journal-title":"Neural Regen. Res."},{"issue":"34","key":"84362_CR72","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.1523\/JNEUROSCI.0148-16.2016","volume":"36","author":"N Ziegler","year":"2016","unstructured":"Ziegler, N. et al. \u03b2-catenin is required for endothelial Cyp1b1 regulation influencing metabolic barrier function. J. Neurosci.: Off. J. Soc. Neurosci. 36(34), 8921\u20138935 (2016).","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"2","key":"84362_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/17460441.2017.1271321","volume":"12","author":"A Serafino","year":"2017","unstructured":"Serafino, A. et al. Developing drugs that target the Wnt pathway: Recent approaches in cancer and neurodegenerative diseases. Expert Opin. Drug Discov. 12(2), 169\u2013186 (2017).","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"84362_CR74","first-page":"2194","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. CYP1B1 deiciency ameliorates learning and memory deficits caused by high fat diet in mice. Am. J. Transl. Res. 11(4), 2194\u20132206 (2019).","journal-title":"Am. J. Transl. Res."},{"issue":"10","key":"84362_CR75","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1039\/D3SC06997D","volume":"15","author":"J Yim","year":"2024","unstructured":"Yim, J. et al. Inflachromene ameliorates Parkinson\u2019s disease by targeting Nrf2-binding Keap1. Chem. Sci. 15(10), 3588\u20133595 (2024).","journal-title":"Chem. Sci."},{"key":"84362_CR76","doi-asserted-by":"publisher","first-page":"205520762311698","DOI":"10.1177\/20552076231169846","volume":"9","author":"W Wang","year":"2023","unstructured":"Wang, W., Liu, T. & Zhang, Y. An integrated targeted metabolomics and network pharmacology approach to exploring the mechanism of ellagic acid against sleep deprivation-induced memory impairment and anxiety. Digit. Health 9, 20552076231169850 (2023).","journal-title":"Digit. Health"},{"issue":"2","key":"84362_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymgme.2006.01.009","volume":"88","author":"M Schiff","year":"2006","unstructured":"Schiff, M. et al. Electron transfer flavoprotein deficiency: Functional and molecular aspects. Mol. Genet. Metab. 88(2), 153\u2013158 (2006).","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"84362_CR78","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: What we know so far. Brain J. Neurol. 147(10), 3306\u20133324 (2024).","journal-title":"Brain J. Neurol."},{"issue":"2","key":"84362_CR79","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/jn.00429.2023","volume":"131","author":"Y Han","year":"2024","unstructured":"Han, Y. et al. Analysis of the correlation between immune cell characteristics and insomnia: A Mendelian randomization study. J. Neurophysiol. 131(2), 176\u2013186 (2024).","journal-title":"J. Neurophysiol."},{"issue":"7","key":"84362_CR80","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura, Y. et al. Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276(7), 4812\u20134818 (2001).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"84362_CR81","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.7150\/thno.57218","volume":"12","author":"J Li","year":"2022","unstructured":"Li, J. et al. Critical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice. Theranostics 12(7), 3024\u20133044 (2022).","journal-title":"Theranostics"},{"issue":"6","key":"84362_CR82","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz, J. et al. Meta-analyses identify differentially expressed micrornas in Parkinson\u2019s disease. Ann. Neurol. 85(6), 835\u2013851 (2019).","journal-title":"Ann. Neurol."},{"issue":"4","key":"84362_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151965","volume":"225","author":"X Gao","year":"2020","unstructured":"Gao, X. et al. Beta-naphthoflavone inhibits LPS-induced inflammation in BV-2 cells via AKT\/Nrf-2\/HO-1-NF-\u03baB signaling axis. Immunobiology 225(4), 151965 (2020).","journal-title":"Immunobiology"},{"issue":"11","key":"84362_CR84","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.3390\/ijms21113955","volume":"21","author":"J Fernandez-Abascal","year":"2020","unstructured":"Fernandez-Abascal, J. et al. \u03b2-Naphthoflavone and ethanol reverse mitochondrial dysfunction in a Parkinsonian model of neurodegeneration. Int. J. Mol. Sci. 21(11), 3955 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"84362_CR85","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.3390\/ijms19113369","volume":"19","author":"J Fernandez-Abascal","year":"2018","unstructured":"Fernandez-Abascal, J. et al. \u03b2-hrome P450 and Protect towards MPP\u207a toxicity in human neuroblastoma SH-SY5Y cells. Int. J. Mol. Sci. 19(11), 3369 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"84362_CR86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1208\/s12249-024-02936-1","volume":"25","author":"V Giradkar","year":"2024","unstructured":"Giradkar, V., Mhaske, A. & Shukla, R. Naringenin nanocrystals mitigate rotenone neurotoxicity in SH-SY5Y cell line by modulating mitophagy and oxidative stress. AAPS PharmSciTech 25(7), 227 (2024).","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"84362_CR87","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/acschemneuro.1c00548","volume":"13","author":"F Muhammad","year":"2022","unstructured":"Muhammad, F. et al. Anti-\u03b1-synuclein toxicity and anti-neurodegenerative role of chrysin in transgenic caenorhabditis elegans models of Parkinson\u2019s disease. ACS Chem. Neurosci. 13(4), 442\u2013453 (2022).","journal-title":"ACS Chem. Neurosci."},{"issue":"23","key":"84362_CR88","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1016\/j.bmcl.2017.10.048","volume":"27","author":"SM Kim","year":"2017","unstructured":"Kim, S. M. et al. Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson\u2019s disease model. Bioorg. Med. Chem. Lett. 27(23), 5207\u20135212 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"84362_CR89","doi-asserted-by":"publisher","first-page":"106205","DOI":"10.1016\/j.fitote.2024.106205","volume":"179","author":"X Kong","year":"2024","unstructured":"Kong, X. et al. Sleep-improving effect and the potential mechanism of Morus alba L. on mice. Fitoterapia 179, 106205 (2024).","journal-title":"Fitoterapia"},{"key":"84362_CR90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.11.006","volume":"63","author":"Y Miki","year":"2018","unstructured":"Miki, Y. et al. Alteration of autophagy-related proteins in peripheral blood mononuclear cells of patients with Parkinson\u2019s disease. Neurobiol. Aging 63, 33\u201343 (2018).","journal-title":"Neurobiol. Aging"},{"key":"84362_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.640266","volume":"12","author":"AR Henderson","year":"2021","unstructured":"Henderson, A. R. et al. DNA methylation and expression profiles of whole blood in Parkinson\u2019s disease. Front. Genet. 12, 640266 (2021).","journal-title":"Front. Genet."},{"issue":"1","key":"84362_CR92","doi-asserted-by":"publisher","first-page":"15446","DOI":"10.1038\/s41598-018-33921-x","volume":"8","author":"F Atashrazm","year":"2018","unstructured":"Atashrazm, F. et al. Reduced glucocerebrosidase activity in monocytes from patients with Parkinson\u2019s disease. Sci. Rep. 8(1), 15446 (2018).","journal-title":"Sci. Rep."},{"issue":"13","key":"84362_CR93","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/mds.26433","volume":"30","author":"N Papagiannakis","year":"2015","unstructured":"Papagiannakis, N. et al. Lysosomal alterations in peripheral blood mononuclear cells of Parkinson\u2019s disease patients. Mov. Disorders Off. J. Mov. Disorder Soc. 30(13), 1830\u20131834 (2015).","journal-title":"Mov. Disorders Off. J. Mov. Disorder Soc."},{"issue":"5456","key":"84362_CR94","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah, E. et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (New York, N.Y.) 287(5456), 1265\u20131269 (2000).","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"84362_CR95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou, A. et al. Animal models of Parkinson\u2019s disease: Bridging the gap between disease hallmarks and research questions. Transl. Neurodegener. 12(1), 36 (2023).","journal-title":"Transl. Neurodegener."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84362-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84362-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84362-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T13:05:16Z","timestamp":1736341516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84362-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84362-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Zhengzhou University (ZZU-LAC20240531[06]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"1362"}}